Assyro AI

FDA Orange Book · active-ingredient family

Hydrocodone bitartrate; ibuprofen

Hydrocodone bitartrate; ibuprofen is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:VICOPROFEN · NDA 020716

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
VICOPROFENRLDABBVIENDA 020716Sep 23, 1997

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
HYDROCODONE BITARTRATE AND IBUPROFENAUROLIFE PHARMA LLCANDA 204575ABJun 02, 2016
HYDROCODONE BITARTRATE AND IBUPROFEN×4SUN PHARM INDS INCANDA 091633May 28, 2013
HYDROCODONE BITARTRATE AND IBUPROFENANI PHARMSANDA 077454Jun 23, 2010
HYDROCODONE×3STRIDES PHARMAANDA 077723Nov 06, 2006
HYDROCODONE BITARTRATE AND IBUPROFEN×4AMNEAL PHARMS NYANDA 076642Mar 18, 2004
HYDROCODONE BITARTRATE AND IBUPROFENACTAVIS LABS FL INCANDA 076604ABDec 31, 2003
HYDROCODONE BITARTRATE AND IBUPROFENTEVAANDA 076023Apr 11, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Hydrocodone bitartrate; ibuprofen — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.